Prospective Multicenter Randomized and Controlled Study Evaluating the Benefit of Early Pulmonary Vein Isolation Compared to Usual Treatment in Patients Aged Over 75 Years and Presenting With Atrial Fibrillation

NCT06322017 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

294

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

PROCEDURE: Rhythm control by Pulmonary Vein Isolation (PVI) procedure
DRUG: Conventional care by antiarrhythmic drugs (flecainide, sotalol, amiodarone) or bradycardic drugs (all betablocker or calcium channel blocker therapy, digoxin)

Sponsor

Nantes University Hospital